Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: Implications for pathologic classification

American Journal of Surgical Pathology

Volumn 33, Issue 12, 2009, Pages 1840-1849

  Zhou, Ming ^a   Yang, Ximing J ^b   Lopez, Jose I ^c   Shah, Rajal B ^d   Hes, Ondrej ^e   Shen, Steven S ^f   Li, Rongshan ^g   Yang, Yu ^h   Lin, Fan ⁱ   Elson, Paul ^a   Sercia, Linda ^a   Magi Galluzzi, Cristina ^a   Tubbs, Ray ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d UNIVERSITY OF MICHIGAN   (United States)

^e CHARLES UNIVERSITY   (Czech Republic)

^f HOUSTON METHODIST HOSPITAL   (United States)

^g Wisconsin Medical College   (United States)

^h PEKING UNIVERSITY   (China)

ⁱ GEISINGER MEDICAL CENTER   (United States)

Author keywords

Cytogenetics; Kidney; Papillary carcinoma; Tubulocystic carcinoma

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CHEMISTRY; CHINA; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME ABERRATION; CLASSIFICATION; CLINICAL TRIAL; CYTOGENETICS; EUROPE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUBULE; KIDNEY TUMOR; MALE; MIDDLE AGED; MULTICENTER STUDY; PAPILLARY CARCINOMA; PATHOLOGY; UNITED STATES; Y CHROMOSOME;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CHINA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, Y; CYTOGENETICS; EUROPE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; KIDNEY TUBULES; MALE; MIDDLE AGED; NEOPLASM STAGING; UNITED STATES;

EID: 73349126119     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181be22d1     Document Type: Article

References (22)

1. Amin MB, Maclennan GT, Gupta R, et al. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2009;33: 384-392.
2. Azoulay S, Vieillefond A, Paraf F, et al. Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch. 2007; 451:905-909.
3. Cheng L, Zhang S, MacLennan GT, et al. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol. 2009;40:10-29.
4. Corless CL, Aburatani H, Fletcher JA, et al. Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn Mol Pathol. 1996;5:53-64.
5. Crispen PL, Lohse CM, Blute ML. Multifocal renal cell carcinoma: clinicopathologic features and outcomes for tumors ≥ = 4 cm. Adv Urol. 2008; doi:10.1155/2008/518091
6. Dijkhuizen T, Van den Berg E, Van den Berg A, et al. Chromosomal findings and p53-mutation analysis in chromophilic renal-cell carcinomas. Int J Cancer. 1996;68:47-50.
7. Furge KA, Lucas KA, Takahashi M, et al. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res. 2004;64:4117-4121.
8. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239-1245.
9. Higgins JP, Shinghal R, Gill H, et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol. 2003;162:925-932.
10. MacLennan GT, Bostwick DG. Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors. Clin Lab Med. 2005;25:393-416.
11. MacLennan GT, Farrow GM, Bostwick DG. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology. 1997;50:679-684.
12. Richstone L, Scherr DS, Reuter VR, et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol. 2004;171:615-620.
13. Rohan S, Tu JJ, Kao J, et al. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin Cancer Res. 2006;12:6937-6945.
14. Schuetz AN, Yin-Goen Q, Amin MB, et al. Molecular classification of renal tumors by gene expression profiling. J Mol Diagn. 2005; 7:206-218.
15. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol. 2005; 22:51-68.
16. Takahashi M, Yang XJ, Lavery TT, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res. 2002;62:6598-6605.
17. Takahashi M, Sugimura J, Yang X, et al. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Adv Cancer Res. 2003;89:157-181.
18. Tretiakova MS, Sahoo S, Takahashi M, et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004;28:69-76.
19. Yang XJ, Sugimura J, Schafernak KT, et al. Classification of renal neoplasms based on molecular signatures. J Urol. 2006;175:2302-2306.
20. Yang XJ, Zhou M, Hes O, et al. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol. 2008;32:177-187.
21. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001;158:1639-1651.
22. Zhou M, Chinnaiyan AM, Kleer CG, et al. Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol. 2002;26:926-931.